Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M14.8Revenue (TTM) $M10.9Net Margin (%)24.7Altman Z-Score-34.3
Enterprise Value $M13.8EPS (TTM) $0.9Operating Margin %25.5Piotroski F-Score5
P/E(ttm)8.5Beneish M-Score--Pre-tax Margin (%)24.7Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio0.4Cash flow > EarningsN
Price/Sales1.75-y EBITDA Growth Rate %-23.7Current Ratio0.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)166Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M2.0ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with OPNT

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

OPNT is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


OPNT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sinclair MichaelExecutive Chairman, 10% Owner 2017-01-17Buy3,500$7.013.42view
Pollack KevinSee Remarks 2017-01-13Buy4,820$6.983.87view
Sinclair MichaelExecutive Chairman, 10% Owner 2015-01-15Sell1,700$3.5107.14view
Sinclair MichaelExecutive Chairman, 10% Owner 2015-01-15Sell1,700$3.5107.14view
COHEN MARC AChairman,CEO,Treas, & Sec, 10% Owner 2012-06-14Sell243$2450-99.7view
KAISER RONALD WDirector 2012-06-06Sell100$2604-99.72view
KAISER RONALD WDirector 2010-12-08Sell100$2608-99.72view
Wesley Melvin IIICFO 2010-11-29Sell11$2424-99.7view
Wesley Melvin IIICFO 2010-11-18Sell23$2190-99.67view
COHEN ALAIN JPresident & Chief Tech Officer, 10% Owner 2010-07-27Sell2$1515-99.52view

Quarterly/Annual Reports about OPNT:

News about OPNT:

Articles On GuruFocus.com
No related article found.

More From Other Websites
OPIANT PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 18 2017
Opiant Pharmaceuticals Announces 2017 Corporate and Clinical Goals Jan 11 2017
[$$] Spare5 Rebrands As Mighty AI, Raises $14 Million Jan 10 2017
Opiant Pharmaceuticals Featured in Recent Media Highlighting NARCAN® Nasal Spray and Heroin Vaccine... Jan 09 2017
OPIANT PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events Jan 06 2017
OPIANT PHARMACEUTICALS, INC. Financials Dec 21 2016
Opiant Pharmaceuticals, Inc. :OPNT-US: Earnings Analysis: Q1, 2017 By the Numbers : December 20,... Dec 20 2016
OPNT: Receives $13.7M From Monetizing NARCAN® Nasal Spray Royalties Dec 19 2016
OPIANT PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Dec 19 2016
Opiant Pharmaceuticals, Inc., Reports Fiscal First Quarter 2017 Financial Results and Provides... Dec 16 2016
OPIANT PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... Dec 15 2016
Opiant Pharmaceuticals, Inc. Announces NARCAN® Nasal Spray Royalty Monetization Dec 15 2016
OPIANT PHARMACEUTICALS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in... Nov 22 2016
Opiant Pharmaceuticals, Inc. :OPNT-US: Earnings Analysis: 2016 By the Numbers : November 22, 2016 Nov 22 2016
OPIANT PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers,... Nov 10 2016
Opiant Pharmaceuticals, Inc. Announces Appointment of Thomas T. Thomas to Board of Directors Nov 10 2016
Opiant Pharmaceuticals, Inc. :OPNT-US: Earnings Analysis: Q4, 2016 By the Numbers : November 4, 2016 Nov 04 2016
Opiant Pharmaceuticals, Inc. Reports Fiscal Fourth Quarter and Full Year 2016 Financial Results and... Oct 31 2016
OPIANT PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report Oct 28 2016
Opiant Pharmaceuticals, Inc. Licenses Heroin Vaccine From Walter Reed Army Institute of Research and... Oct 28 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)